Homoepathy treatment in patients of primary tumours of the brain.

Effectiveness of individualized homoeopathic treatment in primary tumours of the brain:an open label,prospective,clinical study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069245

Enrollment

Registered

2024-06-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C719- Malignant neoplasm of brain, unspecified

Interventions

Intervention1: Individualised Homoeopathic Treatment: Indicated individualized homoeopathic medicine will be prescribed after a proper homoeopathic case taking. Dose and frequency of the selected medi

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are diagnosed cases of primary tumours of brain. Patients of age 18 -65 years. Patients of all genders and religions and all socio-economic status. Patient who are willing to participate in the study and giving informed consent.

Exclusion criteria

Exclusion criteria: Patients who are having secondary metastasis to brain. Patients associated with serious systemic disorders or life-threatening infections. Pregnant and lactating women. Self-reported immune-compromised conditions. Patients who are not willing to take part in the study.

Design outcomes

Primary

Measure	Time frame
FACT-BR scaleTimepoint: Baseline and after 6 months	—

Secondary

Measure	Time frame
MRI neuroimaging studiesTimepoint: Baseline and after 6 months	—

Countries

India

Contacts

Public ContactChintha Sushmitha

National Institute of Homoeopathy

drrkghoshnih@gmail.com8777656585

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026